乳腺影像报告和数据系统对中央型导管内乳头状肿块的分类:当前问题与改良参数的评估
该回顾性研究纳入56例中央型乳腺导管乳头状肿块患者,总结其超声影像特征。鉴别良恶性最显著的指标为边缘成角和肿瘤长径平行于导管;术后病理恶性升级率BI-RADS标准为33.3%,新标准为14.2%,肿瘤壁相对导管的角度最有帮助。
要点
- 中央型导管内乳头状肿块良恶性鉴别最重要的超声指标为边缘成角和肿瘤长径平行于导管。
- 术后病理恶性升级率BI-RADS标准为33.3%,新标准为14.2%。
- 评估中央导管内乳头状肿块时,肿瘤平行于导管比平行于皮肤更准确。
关键影像表现/征象
- 中央型乳腺导管乳头状肿块的超声表现包括边缘成角和肿瘤长径平行于导管。
- 肿瘤壁相对导管的角度对鉴别良恶性最有帮助。
诊断标准与关键数值
- 鉴别良恶性最显著的指标为边缘成角和肿瘤长径平行于导管。
- 术后病理恶性升级率:BI-RADS标准为33.3%,新标准为14.2%。
- 评估中央导管内乳头状肿块时,肿瘤平行于导管比平行于皮肤更准确。
临床应用与阅片要点
- 评估中央型导管内乳头状肿块时,应关注肿瘤长径与导管的关系及边缘成角。
- 使用BI-RADS评估中央导管内乳头状肿块时,肿瘤平行于导管比平行于皮肤更准确。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The Breast Imaging Reporting and Data System (BI-RADS) standards have limitations regarding classifying and managing central intra-ductal papillary masses. Changes to the standards are necessary to provide early and effective treatment. To summarize the ultrasonographic imaging features of central mammary ductal papillary masses, this retrospective study included 56 participants. In identifying benign versus malignant lesions, the most significant indicators were angular edges and the long diameter of the tumor parallel to the duct. In the comparison of diagnostic efficacy for central mammary ductal tumors, the post-operative pathologic malignant upgrade rate of BI-RADS was 33.3%, and that of the new standard criteria was 14.2%. The angle of the wall of the tumor relative to the duct was most helpful. When BI-RADS is used to evaluate a papillary mass in a central duct, it is more accurate when the tumor is parallel to the duct than parallel to the skin.
引用
- Zhang H, Sun Y, Zhang J, et al. Breast Imaging Reporting and Data System Classification for Central-Type Intra-Ductal Papillary Masses: Current Problems and Evaluation of Modified Parameters. Ultrasound Med Biol. 2021. PMID: 33455809. doi:10.1016/j.ultrasmedbio.2020.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。